The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant therapy of HER2 directed conventional dendritic cell (DC1) intratumoral (IT) therapy plus weekly paclitaxel, trastuzumab, and pertuzumab in patients with HER-2 positive breast cancer: NATASHA trial.
 
Hyo S. Han
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Immunomedics; Immunomedics/Gilead; Novartis
Speakers' Bureau - Lilly
Research Funding - Abbvie (Inst); Arvinas (Inst); Department of Defense (Inst); G1 Therapeutics (Inst); GlaxoSmithKline (Inst); Horizon Oncology Research (Inst); Marker Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Phoenix Pharmaceuticals (Inst); QuantumLeap Health (Inst); Seagen (Inst); Zymeworks (Inst)
 
Ricardo L Costa
Stock and Other Ownership Interests - Dare Bioscience; Spero Therapeutics
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Pfizer; Sermonix Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Pfizer; Sermonix Pharmaceuticals
 
Avan J. Armaghani
No Relationships to Disclose
 
Susan Hoover
Consulting or Advisory Role - Mammotome
 
John Kiluk
No Relationships to Disclose
 
Marie Catherine Lee
Leadership - Medtronic (I)
Research Funding - Elucent Medical
Travel, Accommodations, Expenses - Amgen
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Novartis; Puma Biotechnology; Seagen
Speakers' Bureau - Merck
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - Celeyad licensing agreement (Inst)
 
Hung T. Khong
Stock and Other Ownership Interests - agenus; Lipocine; MEI Pharma; MustangBio; TG Therapeutics; Tiziana Life Sciences; Vaxart
Consulting or Advisory Role - Celcuity
Research Funding - AstraZeneca
 
Loretta S. Loftus
Stock and Other Ownership Interests - Abbvie; Amgen; Gilead Sciences; Johnson & Johnson; Lilly O.; Pfizer
Consulting or Advisory Role - Cardinal Health
Travel, Accommodations, Expenses - Cardinal Health
 
Qianxing Mo
No Relationships to Disclose
 
Jennifer A Childress
No Relationships to Disclose
 
Edith Abraham
No Relationships to Disclose
 
Kaitlin Hendrix
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Sanofi
 
Amy Aldrich
No Relationships to Disclose
 
Marina Sehovic
No Relationships to Disclose
 
Zena Jameel
Honoraria - The Dedham Group
 
Shannon Falcon
No Relationships to Disclose
 
Robert J Weinfurtner
No Relationships to Disclose
 
Aixa Elena Soyano Muller
Honoraria - FLASCO; OncLive/MJH Life Sciences
Consulting or Advisory Role - Lilly; Novartis
 
Brian J. Czerniecki
Research Funding - Turnstone Bio
Patents, Royalties, Other Intellectual Property - ImmunoRestoration